• Mashup Score: 4
    GI Injury After Antiplatelet Therapy Nearly Universal | Physician's Weekly - 3 year(s) ago

    But one, instead of two, antiplatelets led to less damage Among patients who completed 6 months of dual antiplatelet therapy (DAPT) after successful percutaneous coronary intervention (PCI), gastrointestinal injury was lower in those who replaced DAPT with single antiplatelet therapy (SAPT) for the next 6 months, the OPT-PEACE randomized trial showed. Gastrointestinal mucosal injury including…

    Source: www.physiciansweekly.com
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of ACCmediacenter
      ACCmediacenter

      “Despite being at low risk of bleeding, nearly all patients receiving #antiplatelet therapy developed #GI, although overt bleeding was infrequent,” Dr. Yaling Han concluded from #JACC study. @physicianswkly https://t.co/1USOwdELcq

  • Mashup Score: 0
    Home - 4 year(s) ago

    Dear Colleagues: It is my pleasure and privilege to welcome you to the 2nd Annual Going Back to the Heart of Cardiology 2021 Virtual Conference. This year’s conference will build on the success of last year’s event which included more than 2,500 registered attendees and raised $55,000 as…

    Source: na.eventscloud.com
    Categories: Dermatology, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of MedscapeLIVE
      MedscapeLIVE

      Don't miss Session 2 of #BackToHeart21 on December 7. Session 2 will be on #Arrhythmias, #Anticoagulation, and #Antiplatelet Therapy and feature @manesh_patelMD @JonPicciniSr @Drroxmehran @AlexSpyropoul ➡️ Register now: https://t.co/cCHSFWPuat #CardioTwitter https://t.co/52mwplGUE6

  • Mashup Score: 6
    TCT 2021 - 4 year(s) ago

    Educational Grant SupportTCT is sponsored by the Cardiovascular Research Foundation (CRF) and partially funded through educational grants from commercial supporters.This program is made possible in part by the educational grant support of our industry colleagues who, like CRF, are dedicated to educating medical professionals and the public to enhance patient outcomes. CRF gratefully acknowledges…

    Source: tct2021.crfconnect.com
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of crfheart
      crfheart

      Curious about #TVT studies, plaque modification, #endovascular interventions, or #antiplatelet drug studies? Don't miss today's poster sessions at #TCT2021. https://t.co/RLWjT6RHxB @JoaoLCavalcante @brijmaini @NWeissmanMD @jgschwartzmd @IssamDMoussa1 @DrBillGray @SandeepNathanMD https://t.co/QsL5GXjF4U

  • Mashup Score: 5
    Antiplatelet therapy confers positive outcomes during COVID-19 hospitalization - 4 year(s) ago

    During hospitalization for COVID-19, patients who received antiplatelet therapy demonstrated lower risk for mortality and shorter mechanical ventilation duration compared with those who did not receive it, researchers reported. “Clinical deterioration in COVID-19 seems mainly due to a combination of hyperinflammation, endotheliitis and coagulopathy,” Francesco Santoro, MD,

    Source: www.healio.com
    Categories: Cardiology News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of CardiologyToday
      CardiologyToday

      Patients who received #antiplatelet therapy during #COVID19 hospitalization demonstrated lower #mortality risks and shorter duration of #mechanicalventilation, according to study results published in @Heart_BMJ @InfectDisNews @HealioPulm #Cardiotwitter https://t.co/kOKZsWHB0o

Load More